- Home
- MKZR vs SSKN Comparison
MKZR vs SSKN Comparison
Compare MKZR & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- SSKN
- Stock Information
- Founded
- MKZR 2012
- SSKN 1989
- Country
- MKZR United States
- SSKN United States
- Employees
- MKZR N/A
- SSKN N/A
- Industry
- MKZR
- SSKN Medical/Dental Instruments
- Sector
- MKZR
- SSKN Health Care
- Exchange
- MKZR Nasdaq
- SSKN Nasdaq
- Market Cap
- MKZR 10.3M
- SSKN 8.9M
- IPO Year
- MKZR N/A
- SSKN 2005
- Fundamental
- Price
- MKZR $0.63
- SSKN $1.96
- Analyst Decision
- MKZR
- SSKN Strong Buy
- Analyst Count
- MKZR 0
- SSKN 1
- Target Price
- MKZR N/A
- SSKN $6.00
- AVG Volume (30 Days)
- MKZR 536.4K
- SSKN 49.8K
- Earning Date
- MKZR 08-11-2025
- SSKN 08-13-2025
- Dividend Yield
- MKZR 55.53%
- SSKN N/A
- EPS Growth
- MKZR N/A
- SSKN N/A
- EPS
- MKZR N/A
- SSKN N/A
- Revenue
- MKZR $23,037,348.00
- SSKN $33,620,000.00
- Revenue This Year
- MKZR N/A
- SSKN $3.31
- Revenue Next Year
- MKZR N/A
- SSKN $9.67
- P/E Ratio
- MKZR N/A
- SSKN N/A
- Revenue Growth
- MKZR 52.64
- SSKN 3.30
- 52 Week Low
- MKZR $0.60
- SSKN $1.86
- 52 Week High
- MKZR $5.50
- SSKN $3.79
- Technical
- Relative Strength Index (RSI)
- MKZR N/A
- SSKN 29.46
- Support Level
- MKZR N/A
- SSKN $2.01
- Resistance Level
- MKZR N/A
- SSKN $2.43
- Average True Range (ATR)
- MKZR 0.00
- SSKN 0.16
- MACD
- MKZR 0.00
- SSKN -0.04
- Stochastic Oscillator
- MKZR 0.00
- SSKN 14.08
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.